Celularity Inc. (CELU) — Analyst outlook / Analyst consensus target is. Based on 6 analyst ratings, the consensus is bullish — 3 Buy, 2 Hold, 1 Sell.
The consensus price target is $3.00, representing an upside of 130.8% from the current price $1.30.
Analysts estimate Earnings Per Share (EPS) of $-5.70 and revenue of $0.02B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-2.64 vs est $-5.70 (beat +53.7%). Analyst accuracy: 0%.
CELU Stock — 12-Month Price Forecast
$3.00
▲ +130.77% Upside
Average Price Target
Based on 6 Wall Street analysts offering 12-month price targets for Celularity Inc., the price target is $3.00.
The average price target represents a +130.77% change from the last price of $1.30.
CELU Analyst Ratings
Buy
Based on 6 analysts giving stock ratings to Celularity Inc. in the past 3 months
EPS Estimates — CELU
0%
Analyst Accuracy
Inaccurate
1 year compared
Actual vs Estimate
2024
Actual –$2.64
vs Est –$5.70
▲ 115.9% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
Revenue Estimates — CELU
36%
Analyst Accuracy
Inaccurate
1 year compared
Actual vs Estimate
2024
Actual $0.054B
vs Est $0.020B
▲ 63.8% off
Revenue Trend
Analysts forecast revenue contraction ahead.
